Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: Targeted therapeutics based on engineered proteins that bind EGFR Filling date: 6 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Filling date: 6 Sep 2025 Issue date: 22 Sep 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A BENZOTRIAZOLE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: TREATMENT OF CANCER WITH ANTI-GITR AGONIST ANTIBODIES Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Grant | Utility: Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: GSK-3 inhibitors Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Application | Utility: USE OF ALKALINE WASHES DURING CHROMATOGRAPHY TO REMOVE IMPURITIES Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: ALKENE COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Grant | Utility: Fast-off rate serum albumin binding fibronectin type III domains Filling date: 6 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION Filling date: 6 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: VECTORS FOR VARIABLE REGION SEQUENCE SCREENING Filling date: 6 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS Filling date: 6 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: GSK-3 inhibitors Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Diamide macrocycles having factor XIa inhibiting activity Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES Filling date: 6 Sep 2025 Issue date: 20 Aug 2020 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Indazole derivatives as .alpha.v integrin antagonists Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Compounds useful as immunomodulators Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: CARBAZOLE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: THERAPEUTIC TREM-1 PEPTIDES Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: ONLINE BIOMASS CAPACITANCE MONITORING DURING LARGE SCALE PRODUCTION OF POLYPEPTIDES OF INTEREST Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Use of caprylic acid precipitation for protein purification Filling date: 6 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANTIBODY DIRECTED AGAINST CD28 Filling date: 6 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD PROTEINS Filling date: 6 Sep 2025 Issue date: 6 Aug 2020 |
Grant | Utility: 4-Azaindole compounds Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Bridged bicyclic compounds as farnesoid X receptor modulators Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Bicyclic heteroaryl substituted compounds Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Application | Utility: METHODS OF TREATING TUMOR Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: SUBSTITUTED INDOLE COMPOUNDS USEFUL AS INHIBITORS OF TLR7/8/9 Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Biaryl kinase inhibitors Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Application | Utility: METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: TREATMENT OF HEMATOLOGIC MALIGNANCIES WITH AN ANTI-CXCR4 ANTIBODY Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Showing 450 to 500 of 772 patents.